Aripiprazole: first of a new class of antipsychotics.
- Published in:
- 2002
- By:
- Publication type:
- Journal Article
Works matching IS 1082801X AND DT 2002 AND VI 37 AND IP 11
Results: 56
1
2
Medication substitution: what do seniors think?
- Published in:
- 2002
- Publication type:
- Journal Article
3
E-prescribing benefits.
- Published in:
- 2002
- Publication type:
- Journal Article
4
HMG CoA reductase inhibitor-induced muscle toxicity: risks, monitoring, and management.
- Published in:
- 2002
- By:
- Publication type:
- Journal Article
5
Charging drug representatives for physician visits: three leaders explain why and how.
- Published in:
- 2002
- Publication type:
- Journal Article
6
Formularies and higher copays reduce drug outlays.
- Published in:
- 2002
- Publication type:
- Journal Article
7
Physician views on formularies and generic drugs.
- Published in:
- 2002
- Publication type:
- Journal Article
8
Average copays for generic drugs, preferred drugs, and nonpreferred drugs, 2000-2002.
- Published in:
- 2002
- Publication type:
- Journal Article
9
Drug and formulariy factoids.
- Published in:
- 2002
- Publication type:
- Journal Article
10
Women with CVD risks benefit just as much as men from long-term ACE-inihibitor therapy.
- Published in:
- 2002
- Publication type:
- Journal Article
11
Warfarin helps reduce cardiovascular risk--but at high risk of bleeding.
- Published in:
- 2002
- Publication type:
- Journal Article
12
Large study brings no clear resolution to debate over tamoxifen (Nolvadex) for breast cancer prevention.
- Published in:
- 2002
- Publication type:
- Journal Article
13
Combination therapy improves LV remodeling in CHF better than monotherapy.
- Published in:
- 2002
- Publication type:
- Journal Article
14
Microbial resistance, preventing herpes transmission at conference forefront.
- Published in:
- 2002
- Publication type:
- Journal Article
15
Options expand for bipolar disorder.
- Published in:
- 2002
- Publication type:
- Journal Article
16
Anticonvulsant reduces migraine headache frequency.
- Published in:
- 2002
- Publication type:
- Journal Article
17
Inhaled corticosteroids may be safe for pregnant women.
- Published in:
- 2002
- Publication type:
- Journal Article
18
Long-term studies find atopic dermatitis drug safe for children and adults.
- Published in:
- 2002
- Publication type:
- Journal Article
19
MS drug carries heart risk.
- Published in:
- 2002
- Publication type:
- Journal Article
20
Drug interactions with migraine drugs.
- Published in:
- 2002
- Publication type:
- Journal Article
21
FDA approves reintroduction of thrombolytic agent.
- Published in:
- 2002
- Publication type:
- Journal Article
22
Cardiomyopathy caution for antipsychotic.
- Published in:
- 2002
- Publication type:
- Journal Article
23
Bisphosphonate adds warnings on renal function, pregnancy.
- Published in:
- 2002
- Publication type:
- Journal Article
24
Fainting risk with sildenafil -- alpha-blocker combination.
- Published in:
- 2002
- Publication type:
- Journal Article
25
Interstitial pneumonia cases, deaths with lung-cancer drug.
- Published in:
- 2002
- Publication type:
- Journal Article
26
Controlled trials confirm HRT risks.
- Published in:
- 2002
- Publication type:
- Journal Article
27
Tamoxifen safe for girls.
- Published in:
- 2002
- Publication type:
- Journal Article
28
Warnings, precautions, adverse reactions expand for antifungal.
- Published in:
- 2002
- Publication type:
- Journal Article
29
Safety studies support different bisphosphonates.
- Published in:
- 2002
- Publication type:
- Journal Article
30
FDA actions in brief.
- Published in:
- 2002
- Publication type:
- Journal Article
31
Fast-track designations.
- Published in:
- 2002
- Publication type:
- Journal Article
32
Priority review.
- Published in:
- 2002
- Publication type:
- Journal Article
33
First-time generic approvals.
- Published in:
- 2002
- Publication type:
- Journal Article
34
Recommendations for approval.
- Published in:
- 2002
- Publication type:
- Journal Article
35
Antiarrhythmic, dyslipidemic agents.
- Published in:
- Formulary, 2002, v. 37, n. 11, p. 600
- Publication type:
- Article
36
Selected literature.
- Published in:
- Formulary, 2002, v. 37, n. 11, p. 600
- Publication type:
- Article
37
Formularies and higher copays reduce drug outlays.
- Published in:
- Formulary, 2002, v. 37, n. 11, p. 599
- Publication type:
- Article
38
New FDA commissioner faces major challenges.
- Published in:
- Formulary, 2002, v. 37, n. 11, p. 598
- By:
- Publication type:
- Article
39
Charging drug representatives for physician visits: Three leaders explain why and how.
- Published in:
- Formulary, 2002, v. 37, n. 11, p. 594
- Publication type:
- Article
40
HMG CoA reductase inhibitor-induced muscle toxicity: risks, monitoring, and management.
- Published in:
- Formulary, 2002, v. 37, n. 11, p. 583
- By:
- Publication type:
- Article
41
Aripiprazole.
- Published in:
- Formulary, 2002, v. 37, n. 11, p. 575
- By:
- Publication type:
- Article
42
NEWLY PUBLISHED STUDIES OF INTEREST TO DRUG DECISION-MAKERS.
- Published in:
- Formulary, 2002, v. 37, n. 11, p. 570
- Publication type:
- Article
43
Drug and Formulary Trends.
- Published in:
- Formulary, 2002, v. 37, n. 11, p. 574
- Publication type:
- Article
44
Combination therapy improves LV remodeling in CHF better than monotherapy.
- Published in:
- Formulary, 2002, v. 37, n. 11, p. 570
- Publication type:
- Article
45
Microbial resistance, preventing herpes transmission at conference forefront.
- Published in:
- Formulary, 2002, v. 37, n. 11, p. 569
- Publication type:
- Article
46
Anticonvulsant reduces migraine headache frequency.
- Published in:
- Formulary, 2002, v. 37, n. 11, p. 569
- Publication type:
- Article
47
Options expand for bipolar disorder.
- Published in:
- Formulary, 2002, v. 37, n. 11, p. 566
- Publication type:
- Article
48
Path still not clear for marketing generic omeprazole.
- Published in:
- Formulary, 2002, v. 37, n. 11, p. 566
- Publication type:
- Article
49
Brief reports.
- Published in:
- Formulary, 2002, v. 37, n. 11, p. 565
- Publication type:
- Article
50
Controlled trials confirm HRT risks.
- Published in:
- Formulary, 2002, v. 37, n. 11, p. 565
- Publication type:
- Article